Purchase Order 75N91024P00473
- Not listed
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $22,324.00 contract is for the provision of various products and services to support the NIH's biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems,...
- This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract has a total ceiling value of $19,008.00 and a period of performance ending on March 30, 2026. The contract does not have a set-aside designation. Qiagen, LLC will provide a range of products and services to support the NIH's biomedical research, public health, and healthcare programs, including...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $10,037.40 contract will provide the NIH with Qiagen's sample and assay technologies to support the agency's biomedical research, public health, and healthcare programs. The contract does not have a set-aside designation. Qiagen has a history of providing a range of products and services to federal...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $11,333.80 contract is for the delivery of specialized products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis tools, and bioinformatics software. Qiagen...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and genomic analysis products. The $389,994.64 contract, which does not have a set-aside designation, is for the delivery of various scientific equipment and consumables to support NIEHS's biomedical research and public health initiatives. Key items included under the contract are DNA/RNA...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC for a maintenance agreement valued at $13,967.00. The contract has an ultimate completion date of August 31, 2025. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. Qiagen has provided a range of...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $11,437.12 contract is for the purchase of QIAGEN KITS & SUPPLIES, which are likely molecular biology products and services used to support NIAID's biomedical research, public health, and healthcare programs. Qiagen is an...
- This is a $10,768.00 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The contract is for the QCII TRANSLATIONAL 1,000 SAMPLES requirement, with a performance period ending on September 28, 2025. Qiagen has provided a range of goods and services to federal agencies in the past, including DNA/RNA extraction kits, next-generation...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $7,820.97 award supports the provision of Qiagen's products and services, which include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, bioinformatics software, and precision medicine analysis tools. Qiagen has a long history...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software. Qiagen has previously served as both a prime contractor and subcontractor to federal agencies such as HHS, Department of Veterans Affairs, Department of Defense, and Department of Justice, providing a range of specialized products and services to support their biomedical research, public health, and healthcare programs. The contract does not have a set-aside designation and is scheduled for completion on May 24, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 5/21/24 |